Trident Pharma Consultants Limited in Fareham, PO15 5TH

Description

Data updated on: 01-11-2023

Trident Pharma Consultants Limited with reg. no. 08222226 has been operating on the market for 12 years. This Private Limited Company is officially located at 1 Manor Court, 6 Barnes Wallis Road Segensworth in Fareham and company's zip code is PO15 5TH. The enterprise's declared SIC number is 46900 meaning Non-specialised wholesale trade. Sat, 31st Dec 2022 is the last time when account status updates were reported.

As stated, this specific firm was founded in 2012 and has been led by two directors.

Executives with significant control over the firm are: Kalyanaraman S. owns 1/2 or less of company shares and has 1/2 or less of voting rights. Usha S. owns 1/2 or less of company shares and has 1/2 or less of voting rights.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	47 570	63 905	125 807

Balance Sheet
Cash Bank In Hand	52 160	87 650	20 141
Cash Bank On Hand			20 141	136 265	145 884	80 900	142 949	71 439	30 589	35 430	74 880
Current Assets	61 894	87 650	155 660	259 979	268 020	296 626	355 247	393 655	421 046	425 954	456 609
Debtors	9 734		135 519	123 714	122 136	215 726	212 298	322 216	390 457	390 524	381 729
Net Assets Liabilities			125 807	198 429	241 444	277 674	332 272	373 763	400 080	405 994	434 415
Net Assets Liabilities Including Pension Asset Liability	47 570	63 905	125 807
Other Debtors			125 319	123 714	121 056	215 726	212 298	322 216
Property Plant Equipment			386	192	68		269	215	172	138	333
Tangible Fixed Assets	405	579	386

Capital & Reserves
Called Up Share Capital	100	100	100
Profit Loss Account Reserve	47 470	63 805	125 707
Shareholder Funds	47 570	63 905	125 807

Other Financial Data
Accumulated Depreciation Impairment Property Plant Equipment			388	582	706	774	793	847	890	924	987
Amounts Owed By Associates								322 216	387 577	380 924	375 969
Creditors			30 162	61 704	26 632	18 952	23 198	20 066	21 105	20 061	22 447
Creditors Due Within One Year	14 648	24 208	30 162
Increase From Depreciation Charge For Year Property Plant Equipment				194	124	68	19	54	43	34	63
Net Current Assets Liabilities	47 246	63 442	125 498	198 275	241 388	277 674	332 049	373 589	399 941	405 893	434 162
Number Shares Allotted	100	100	100
Other Creditors			3 993	32 335	7 338	1 949	1 950	1 829	2 044	1 886	1 845
Other Taxation Social Security Payable			26 169	29 369	19 294	17 003	21 248	18 237	19 061	18 175	20 602
Par Value Share	1	1	1
Property Plant Equipment Gross Cost			774	774	774	774	1 062	1 062	1 062	1 062	1 320
Provisions For Liabilities Balance Sheet Subtotal			77	38	12		46	41	33	37	80
Provisions For Liabilities Charges	81	116	77
Share Capital Allotted Called Up Paid	100	100	100
Tangible Fixed Assets Additions	475	299
Tangible Fixed Assets Cost Or Valuation	475	774
Tangible Fixed Assets Depreciation	70	195	388
Tangible Fixed Assets Depreciation Charged In Period	70	125	193
Total Additions Including From Business Combinations Property Plant Equipment							288				258
Total Assets Less Current Liabilities	47 651	64 021	125 884	198 467	241 456	277 674	332 318	373 804	400 113	406 031	434 495
Trade Debtors Trade Receivables			10 200		1 080				2 880	9 600	5 760

Company staff

Usha S.

Role: Director

Appointed: 18 February 2023

Latest update: 30 December 2023

Kalyanaraman S.

Role: Director

Appointed: 20 September 2012

Latest update: 30 December 2023

People with significant control

Kalyanaraman S.

Notified on 6 April 2016

Nature of control:

1/2 or less of voting rights

right to manage directors

1/2 or less of shares

Usha S.

Notified on 6 April 2016

Nature of control:

1/2 or less of voting rights

1/2 or less of shares

Accounts Documents

Account next due date	30 September 2024
Account last made up date	31 December 2022
Confirmation statement next due date	04 October 2024
Confirmation statement last made up date	20 September 2023

Annual Accounts
Start Date For Period Covered By Report	20 September 2012
End Date For Period Covered By Report	31 December 2013
Annual Accounts 31 January 2015
Start Date For Period Covered By Report	01 January 2014
End Date For Period Covered By Report	31 December 2014
Date Approval Accounts	31 January 2015
Annual Accounts 16 February 2016
Start Date For Period Covered By Report	01 January 2015
End Date For Period Covered By Report	31 December 2015
Date Approval Accounts	16 February 2016
Annual Accounts
Start Date For Period Covered By Report	01 January 2016
End Date For Period Covered By Report	31 December 2016
Annual Accounts
Start Date For Period Covered By Report	01 January 2017
End Date For Period Covered By Report	31 December 2017
Annual Accounts
Start Date For Period Covered By Report	01 January 2018
End Date For Period Covered By Report	31 December 2018
Annual Accounts
Start Date For Period Covered By Report	01 January 2019
End Date For Period Covered By Report	31 December 2019
Annual Accounts
Start Date For Period Covered By Report	01 January 2020
End Date For Period Covered By Report	31 December 2020
Annual Accounts
Start Date For Period Covered By Report	01 January 2021
End Date For Period Covered By Report	31 December 2021
Annual Accounts
Start Date For Period Covered By Report	01 January 2022
End Date For Period Covered By Report	31 December 2022
Annual Accounts
Start Date For Period Covered By Report	01 January 2023
End Date For Period Covered By Report	31 December 2023
Annual Accounts 3 March 2014
Date Approval Accounts	3 March 2014

Trident Pharma Consultants Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Usha S.

Kalyanaraman S.

People with significant control

Kalyanaraman S.

Usha S.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies